Triple-negative breast cancer: Early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathological complete response
暂无分享,去创建一个
D. Groheux | M. Espié | E. Hindié | L. Vercellino | M. Marty | S. Giacchetti | M. Delord | A. Hamy | N. Bérenger | Anne De-roquancourt